Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $35,790 | 18 | 99.6% |
| Food and Beverage | $146.95 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lucid Diagnostics Inc. | $22,502 | 10 | $0 (2024) |
| Infinity BiologiX LLC | $13,000 | 2 | $0 (2022) |
| PFIZER INC. | $287.68 | 6 | $0 (2017) |
| Gen-Probe, Inc. | $146.95 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,649 | 12 | Lucid Diagnostics Inc. ($22,502) |
| 2022 | $6,250 | 1 | Infinity BiologiX LLC ($6,250) |
| 2021 | $6,750 | 1 | Infinity BiologiX LLC ($6,750) |
| 2017 | $287.68 | 6 | PFIZER INC. ($287.68) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Gen-Probe, Inc. | — | Food and Beverage | In-kind items and services | $131.41 | General |
| 11/20/2024 | Gen-Probe, Inc. | — | Food and Beverage | In-kind items and services | $15.54 | General |
| 10/28/2024 | Lucid Diagnostics Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 09/23/2024 | Lucid Diagnostics Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 08/26/2024 | Lucid Diagnostics Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 07/29/2024 | Lucid Diagnostics Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 07/01/2024 | Lucid Diagnostics Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 06/03/2024 | Lucid Diagnostics Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 04/22/2024 | Lucid Diagnostics Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 03/25/2024 | Lucid Diagnostics Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 03/11/2024 | Lucid Diagnostics Inc. | — | Consulting Fee | Cash or cash equivalent | $4,502.42 | General |
| 01/16/2024 | Lucid Diagnostics Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 12/30/2022 | Infinity BiologiX LLC | — | Consulting Fee | Cash or cash equivalent | $6,250.00 | General |
| 02/01/2021 | Infinity BiologiX LLC | — | Consulting Fee | Cash or cash equivalent | $6,750.00 | General |
| 12/04/2017 | PFIZER INC. | BAVENCIO (Drug) | Consulting Fee | Cash or cash equivalent | $3.62 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2017 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $46.91 | General |
| 09/18/2017 | PFIZER INC. | BAVENCIO (Drug) | Consulting Fee | Cash or cash equivalent | $129.37 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2017 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $12.79 | General |
| 08/01/2017 | PFIZER INC. | INLYTA (Drug) | Consulting Fee | Cash or cash equivalent | $17.12 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2017 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $77.87 | General |
About Dr. Jess Savala, M.D
Dr. Jess Savala, M.D is a Anatomic Pathology & Clinical Pathology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1376796086.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jess Savala, M.D has received a total of $35,937 in payments from pharmaceutical and medical device companies, with $22,649 received in 2024. These payments were reported across 20 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($35,790).
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Los Angeles, CA
- Active Since 10/24/2008
- Last Updated 10/24/2008
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1376796086
Products in Payments
- BAVENCIO (Drug) $132.99
- INLYTA (Drug) $17.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Los Angeles
Serge Alexanian, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $2.4M
Brian Cone, D.o, D.O
Anatomic Pathology & Clinical Pathology — Payments: $325,661
Mark Haas, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $140,393
Dr. Michael Lewis, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $83,635
Dr. Nam Ku, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $79,867
Jonathan Braun, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $73,284